featured
Efficacy of Intravitreal 5-Fluorouracil and Heparin in Preventing Proliferative Vitreoretinopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical Trial
Ophthalmology 2022 Oct 01;129(10)1129-1141, F Schaub, P Schiller, R Hoerster, D Kraus, FG Holz, R Guthoff, H Agostini, MS Spitzer, P Wiedemann, A Lommatzsch, KT Boden, S Dimopoulos, S Bemme, S Tamm, M Maier, J Roider, P Enders, L Altay, S Fauser, B KirchhofFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.